I think you're getting a little ahead of yourself. Aurora is...

I think you're getting a little ahead of yourself. Aurora is large, but $50B? There is a plethora of pharmaceuticals playing in this space, many larger than Aurora. Most operate in the USA where recreational MJ has been legal for some time in a number of states.

Competition is high, barriers to entry relatively low. Even CAN recognises there is probably as much money in lab assay services as the product. CAN will grow to be a good company, but a $20 stock (+$2B cap)? Maybe. I'll be happy if they are a 2 or 3 bagger.